Apyx Medical Corp (NASDAQ:APYX) has a beta value of 1.05 and has seen 1.29 million shares traded in the recent trading session. The company, currently valued at $48.52M, closed the recent trade at $1.28 per share which meant it gained $0.17 on the day or 16.20% during that session. The APYX stock price is -52.34% off its 52-week high price of $1.95 and 40.62% above the 52-week low of $0.76.
The consensus among analysts is that Apyx Medical Corp (APYX) is Buy stock at the moment, with a recommendation rating of 2.33. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 3 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight.
Apyx Medical Corp (NASDAQ:APYX) trade information
Sporting 16.20% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the APYX stock price touched $1.28 or saw a rise of 1.54%. Year-to-date, Apyx Medical Corp shares have moved -18.73%, while the 5-day performance has seen it change 20.00%. Over the past 30 days, the shares of Apyx Medical Corp (NASDAQ:APYX) have changed 34.03%.
Wall Street analysts have a consensus price target for the stock at $8.5, which means that the shares’ value could jump 84.94% from the levels at last check today.. The projected low price target is $5.0 while the price target rests at a high of $12.0. In that case, then, we find that the latest price level in today’s session is -837.5% off the targeted high while a plunge would see the stock gain -290.62% from the levels at last check today..
Apyx Medical Corp (APYX) estimates and forecasts
The company’s shares have gained 5.25% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -2.68% over the past 5 years. Earnings growth for 2025 is a modest 40.40% while over the next 5 years, the company’s earnings are expected to increase by 20.63%.
APYX Dividends
Apyx Medical Corp is expected to release its next earnings report in June this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Apyx Medical Corp (NASDAQ:APYX)’s Major holders
The top two institutional holders are ARCHON CAPITAL MANAGEMENT LLC with over 3.12 million shares worth more than $4.17 million. As of 2024-06-30, ARCHON CAPITAL MANAGEMENT LLC held 8.9923% of shares outstanding.
The other major institutional holder is ROYCE & ASSOCIATES LP, with the holding of over 2.5 million shares as of 2024-06-30. The firm’s total holdings are worth over $3.35 million and represent 7.2082% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and ROYCE FUND-Royce Small-Cap Opportunity Fund . As of Dec 31, 2024 , the former fund manager holds about 2.67% shares in the company for having 1.01 shares of worth $1.36 million while later fund manager owns 994.78 shares of worth $1.34 million as of Dec 31, 2024 , which makes it owner of about 2.63% of company’s outstanding stock.
